RIBOMIC, Inc.

Industry

  • Biotechnology
    • Drug Discovery Technologies
      • Molecular Diversity
      • ADMET
    • Large Molecule
    • Antisense, Oligonucleotides
  • Pharmaceuticals

Other Names/Subsidiaries

  • RIBOMIC USA
See more in Biomedtracker

Latest on RIBOMIC, Inc.

Scrip

Asia Deal Watch: Daiichi Sankyo Pays $200m To Ultragenyx For AAV Technology Access

 
• By Ian Haydock, Jung Won Shin, and Joseph Haas

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Daiichi Sankyo Pays $200m Up

In Vivo

Deals Shaping The Medical Industry, October 2014

IN VITRO DIAGNOSTICS Mergers & Acquisitions Laboratory Corp. of America Holdings LipoScience Inc. Laboratory Corp. of America Holdings acquired publicly traded LipoScience Inc. (diagnostics fo